Xiaoyuan Chen
22Patents
3h-index
49Co-inventors
63Inventor score
Filing activity: Nov 12, 1997 → Dec 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8865995B2 | Methods for high figure-of-merit in nanostructured thermoelectric materials | Electricity | 5 | Active |
| US6117413A | Radionuclide-binding compound, a radionuclide delivery system, a method of making a radium complexing compound, a method of extracting a radionuclide, and a method of delivering a radionuclide | Performing Operations; Transporting | 5 | Expired |
| US6075130A | Ion binding compounds, radionuclide complexes, methods of making radionuclide complexes, methods of extracting radionuclides, and methods of delivering radionuclides to target locations | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8168879B2 | Solar thermoelectric conversion | Emerging Cross-Sectional Technologies | 3 | Active |
| US9109846B2 | Polymer sheets and other bodies having oriented chains and method and apparatus for producing same | Mechanical Engineering; Lighting; Heating | 2 | Active |
| US9391255B2 | Multistage thick film thermoelectric devices | Electricity | 1 | Active |
| US7471448B2 | Surface phonon-polariton raman laser | Emerging Cross-Sectional Technologies | 1 | Active |
| US9502240B2 | Preparation method of crystalline silicon film based on layer transfer | Emerging Cross-Sectional Technologies | 1 | Active |
| US9498499B2 | Imaging-aided gene therapy using mesenchymal stem cells as target-delivery vehicle | Chemistry; Metallurgy | 1 | Active |
| US10981866B2 | Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents | Chemistry; Metallurgy | 1 | Active |
| US10709790B2 | Chemical conjugates of Evans Blue derivatives and their use in the production of long-acting therapeutics | Chemistry; Metallurgy | 1 | Active |
| US10469952B2 | Loudspeaker | Electricity | 1 | Active |
| US10696631B2 | Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents | Chemistry; Metallurgy | 1 | Active |
| US11957767B2 | Compound targeting prostate specific membrane antigen, and preparation method and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9903868B2 | Method for the detection and quantitation of biomarkers | Physics | 0 | Active |
| US12161733B2 | Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer | Chemistry; Metallurgy | 0 | Active |
| US10258701B2 | Labeled evans blue dye derivative for in vivo serum albumin labeling | Chemistry; Metallurgy | 0 | Active |
| US9974868B2 | Octapod iron oxide nanoparticles as high performance T2 contrast agents for magnetic resonance imaging | Chemistry; Metallurgy | 0 | Active |
| US11466024B2 | Bicylic compound acting as an inhibitor | Chemistry; Metallurgy | 0 | Active |
| US11992536B2 | Dual-targeting compound and preparation method and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10646591B2 | Imaging agents for imaging protease activity and uses thereof | Human Necessities | 0 | Active |
| US11975079B2 | Truncated Evans Blue modified fibroblast activation protein inhibitor, preparation method and application thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.